RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Clinical trials for RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with recurrent brain tumors in clinical trial
Disease control Recruiting nowThis study is testing an oral medication called binimetinib for children and young adults with a recurrent brain tumor called adamantinomatous craniopharyngioma. The goal is to see if the drug can shrink the tumor and control its growth, especially for patients whose cancer has r…
Matched conditions: RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Arthritis drug could be new weapon against rare childhood brain tumor
Disease control Recruiting nowThis study is testing whether an existing arthritis drug called Actemra (tocilizumab) can help control a rare and difficult-to-treat brain tumor in children and young adults. The trial will enroll up to 38 patients aged 1 to 39 years who have a recurrent or progressive tumor call…
Matched conditions: RECURRENT ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC